Alkem Launches Renocia Exo Hair Regeneration Therapy
MM Desk
23 September, 2026
Alkem Laboratories Ltd (BSE: 539523, NSE: ALKEM) has launched Renocia Exo™, a patented Ginsenoside Exosome-based
Alkem Laboratories Ltd (BSE: 539523, NSE: ALKEM) has launched Renocia Exo™, a patented Ginsenoside Exosome-based
Alkem Laboratories Ltd (BSE: 539523, NSE: ALKEM) has announced the launch of NeuCeno (cenobamate), an
Alkem Laboratories Limited has announced the launch of semaglutide in single-shot pre-filled syringes, becoming the
Alkem Laboratories Ltd has announced the launch of ‘A to Z Daily’, a multivitamin supplement
Alkem Foundation, the social responsibility division of Alkem Laboratories Ltd, has announced a landmark collaboration